POINT Biopharma Announces Closing of Agreements with Lantheus Holdings

December 20, 2022

https://www.globenewswire.com/news-release/2022/12/20/2577066/0/en/POINT-Biopharma-Announces-Closing-of-Agreements-with-Lantheus-Holdings.html

INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (“POINT”) (NASDAQ:PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance, have been met for the previously announced agreements with Lantheus Holdings Inc. (NASDAQ:LNTH).

Read more at globenewswire.com

Related news for (PNT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.